Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 612.20K | 322.80K | 180.30K | 280.20K | 1.80M |
| Total Depreciation and Amortization | 285.80K | 267.40K | 311.80K | 299.80K | 281.10K |
| Total Amortization of Deferred Charges | 24.90K | 25.50K | -- | -- | -- |
| Total Other Non-Cash Items | 211.60K | 188.30K | 92.10K | 223.60K | 223.70K |
| Change in Net Operating Assets | -568.20K | -242.50K | 441.50K | -181.10K | -1.33M |
| Cash from Operations | 566.30K | 561.60K | 1.03M | 622.50K | 984.20K |
| Capital Expenditure | -145.10K | -168.30K | -535.00K | -473.10K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -197.80K | -- | -- |
| Cash from Investing | -145.10K | -168.30K | -732.70K | -473.10K | -27.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -73.20K | -73.30K | -302.50K | -73.30K | -73.30K |
| Issuance of Common Stock | 79.60K | 6.50K | -- | 357.30K | -- |
| Repurchase of Common Stock | -511.30K | -315.00K | -162.60K | -395.10K | -52.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -- | -- | -- |
| Cash from Financing | -360.70K | -280.00K | -339.90K | -82.40K | -92.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.50K | 113.30K | -47.00K | 66.90K | 864.70K |
